COVID19 Pandemic Products

Hand Sanitisers and Disposable Masks

Preparation is Key in
a Pandemic

Everyone who prepares is one less person who panics in a pandemic.

As Sypharma continues to closely monitor the CoVID-19 Pandemic, our primary concern is the health and safety of our staff, customers and the community.

We will continue to deliver our products and we will endeavor to maintain our supply chain at this critical time in order to minimize disruptions to our customers.

In response to the global CoVid-19 Pandemic, Sypharma has the following products. Please contact us for more information.

All Purpose
Hand Sanitizer

70% Alcohol Based Hand Sanitizer (100mL / 500mL/1000mL) Kills 99.9% Germs.

Whilst other cleaning options require a method of wetting, one for drying and potentially a further aid for disinfecting, hand sanitizer performs a complete cleaning operation using just one product.

Easy to use and convenient to carry, hand sanitizer is a compact item that gives great results.

Total Shield 24 Hand Sanitizer

Non-Alcohol Based Hand Sanitizer (500mL) Kills 99.9% Germs

Click Here for Test Report

Unlike traditional sanitizing product such as Ethanol/IPA, Sodium Hypochlorite and Peroxide with irritating smell, TOTALSHIELD-24 has no unpleasant smell and is not flammable.

3-Ply Disposable Face Masks

99% Bacterial Filterability

Click Here for Test Report

Wearing mask is one of the measures to prevent respiratory tract infections. Surgical mask is a type of face mask commonly use.

When used properly, it can help to prevent infections transmitted by respiratory droplets.

Protect yourselves and protect others by always keeping your hands clean, wearing a mask as appropriate and maintaining cough etiquette.

Unlocking resources

Collaboration & Potential

We work together with innovative biotech developers to your drug production destination means the world to us, and our dedicated team of experts will support and guide you from the earliest stage of development through commercialization and beyond.


  • Clinical Development of SpikoGen®

    An Advax-CpG55.2 adjuvanted recombinant spike protein vaccine.

    Read Fact Sheet
  • Ensuring Efficacy and Safety

    The Critical Role of Pharmaceutical Cold Chain Transportation

    Read Fact Sheet
  • University of Queensland partners with Sypharma

    Sypharma partners with The University of Queensland for the manufacture of their CoVID-19 Vaccine Product.

    Read Press Release
  • Technovalia, Sypharma and BioNet announce the establishment of Genetis

    Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines.

    Read Press Release

Since 2005 unlocking healthier futures.